Skip to main content Skip to search




Parathyroidectomy– a surgical procedure aimed at removing one or more of the parathyroid glands– stands as a cornerstone in the management of hyperparathyroidism, a condition characterized by excessive secretion of parathyroid hormone (PTH). Through international research and clinical advancements, parathyroidectomy has emerged as a safe and effective intervention for restoring calcium balance and alleviating the debilitating symptoms associated with hyperparathyroidism.

Hyperparathyroidism, whether primary, secondary, or tertiary, poses significant health risks, including bone loss, kidney stones, and metabolic disturbances. Despite the availability of pharmacological therapies to manage hyperparathyroidism, parathyroidectomy remains the gold standard treatment for patients with severe or refractory disease.

International studies have underscored the efficacy of parathyroidectomy in improving both clinical outcomes and quality of life for individuals burdened by hyperparathyroidism. Research has demonstrated substantial reductions in serum calcium and PTH levels following surgical removal of hyperactive parathyroid tissue, leading to resolution or amelioration of associated symptoms such as bone pain, fatigue, and cognitive impairment.

Furthermore, advancements in surgical techniques, including minimally invasive and focused approaches, have revolutionized the landscape of parathyroidectomy, offering patients shorter operative times, reduced postoperative pain, and faster recovery periods. These innovations have expanded the accessibility of parathyroidectomy to a broader patient population while minimizing the potential for surgical complications.

The decision to pursue parathyroidectomy hinges upon careful consideration of various factors, including disease severity, patient preferences, and surgical risk. International guidelines advocate for a multidisciplinary approach involving endocrinologists, surgeons, and other healthcare professionals to ensure optimal preoperative evaluation, surgical planning, and postoperative management.

While parathyroidectomy typically yields favorable outcomes, certain challenges and considerations warrant attention. For instance, identifying the precise location of abnormal parathyroid glands, particularly in cases of ectopic or supernumerary glands, may require advanced imaging modalities such as sestamibi scintigraphy or ultrasound.

Moreover, postoperative monitoring of calcium and PTH levels is essential to assess the adequacy of surgical resection and to detect potential complications such as hypocalcemia or recurrent hyperparathyroidism. Close collaboration between patients and healthcare providers is paramount to optimize long-term follow-up care and ensure optimal clinical outcomes.

Parathyroidectomy represents a pivotal intervention in the management of hyperparathyroidism, offering a definitive solution for restoring calcium homeostasis and alleviating the burden of associated symptoms. Through international collaboration and research-driven approaches, the field of parathyroid surgery continues to evolve, paving the way for improved patient outcomes and enhanced quality of life. By embracing evidence-based practices and leveraging technological innovations, healthcare professionals can empower individuals with hyperparathyroidism to embark on a path towards renewed health and vitality.

How can ERemedium help?

ERemedium is India’s largest health literacy platform and leading Healthcare Digital platform with a presence in over 5,000 Hospitals and clinics, impacting 20 million patients monthly.

ERemedium works closely with over 10,000+ Doctors to better engage and communicate with patients by 3D videos

MEDXPLAIN: Medxplain is a cloud-based content subscription platform for doctors which acts as a bridge between a doctor and a patient. Medxplain increases patient satisfaction and promotes health literacy at the moment of most significant impact. Doctors can now communicate over 1,000 conditions, procedures, and treatment options with patients in an unprecedented way. The content platform can be opened easily on a mobile, tablet, laptop, or desktop.

The platform comes with full-blown customization and personalization options with exciting features such as real-time sharing, personal content upload, bookmarks, etc.

For more information:

MEDCOMM: 22” Touch screen signage embedded with 3D videos personalized to specialty and care settings. Doctors can now communicate over 1,000 conditions, procedures, and treatment options with patients in an unprecedented way. Medcomm enables quality consultation in less time by use of a copyrighted content library consisting of 3D anatomy, and gesture-driven patient information animations. A centralized knowledge base of the latest research, clinical tools, and medical information at your fingertips. Medcomm is also capable of running promotions which ultimately helps in the digital marketing of pharmaceutical companies.

For more information:

MEDIO: Medio uses OPD Waiting Area TV to increase patient satisfaction, ease waiting time, and promote health literacy at the moment of greatest impact. Doctors use it to promote services, facilities, latest updates and high quality 3D videos to ensure patients feel a connection to your practice. Medio runs 3D patient education Speciality videos and empowers patients with condition-specific videos, and much more while they are waiting to meet the Doctor. Content is approved by top medical associations and personalized to Doctor’s Speciality and Care Setting.

For more information:

2020 Eremedium. All Rights Reserved | Privacy Policy | Terms of Use